Shanghai HeartCare Medical Technology Corporation Limited has formally released its updated Articles of Association, addressing the company’s governance structure, share issuance protocols, and shareholder rights. The document clarifies procedures for merger, division, and liquidation, as well as shareholder protections and disclosure requirements.

Notable points include: • Clear stipulations on the rights and obligations of shareholders, the Board of Directors, and senior management, emphasizing corporate accountability and compliance with relevant laws. • Detailed provisions governing share classes, issuance methods, buyback, and transfer, highlighting shareholder equity protection and aligned with standards set by Chinese laws and overseas listing regulations. • Guidelines for profit distribution, common reserve fund management, and information disclosure requirements, reflecting a commitment to transparent operations and consistent financial oversight. • Specific rules on convening general shareholders’ meetings, voting procedures, and required quorum levels, aiming to safeguard shareholders’ decision-making rights. • Provisions on appointing and removing auditors, alongside detailed requirements for annual and interim financial reporting, underscoring the importance of independent oversight and robust auditing practices.

The revised Articles of Association are effective from the date of their publication, subject to relevant shareholder approvals and regulatory filings as stipulated by law. Market participants may refer to the full announcement for comprehensive details on corporate governance and shareholder protections. The Board of Directors bears responsibility for interpreting these provisions consistent with statutory norms and best practices.